Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Tabula Rasa Healthcare Inc (TRHC)

Tabula Rasa Healthcare Inc (TRHC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,460,912
  • Shares Outstanding, K 23,021
  • Annual Sales, $ 284,710 K
  • Annual Income, $ -32,440 K
  • 60-Month Beta 1.27
  • Price/Sales 4.78
  • Price/Cash Flow 31.49
  • Price/Book 7.60

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.21
  • Number of Estimates 6
  • High Estimate -0.06
  • Low Estimate -0.44
  • Prior Year 0.13
  • Growth Rate Est. (year over year) -261.54%

Price Performance

See More
Period Period Low Period High Performance
1-Month
52.85 +20.08%
on 05/13/20
66.09 -3.98%
on 04/29/20
+1.15 (+1.85%)
since 04/27/20
3-Month
33.04 +92.07%
on 03/17/20
66.09 -3.98%
on 04/29/20
+6.35 (+11.12%)
since 02/27/20
52-Week
33.04 +92.07%
on 03/17/20
69.72 -8.98%
on 02/21/20
+19.63 (+44.79%)
since 05/24/19

Most Recent Stories

More News
TRHC's MedWise Risk Score(TM) Reduces the Odds of Adverse Drug Events, Keeping Patients Safer

Article published in peer-reviewed Pharmacy showcases the power of TRHC's multi-drug medication decision support tool

TRHC : 63.46 (+7.30%)
TRHC Fills the Information Gap on COVID-19 Proposed Therapies with a New Digital Resource

Tabula Rasa HealthCare(R) Corporation (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today published on the web the TRHC COVID-19 Treatment and Therapy Digital...

TRHC : 63.46 (+7.30%)
HMSY or TRHC: Which Is the Better Value Stock Right Now?

HMSY vs. TRHC: Which Stock Is the Better Value Option?

HMSY : 30.71 (+5.71%)
TRHC : 63.46 (+7.30%)
TRHC and ASCP Sign Letter of Intent to offer MedWise(TM) to Consultant Pharmacists

Tabula Rasa HealthCare, Inc. (TRHC) (Nasdaq: TRHC), a healthcare technology company advancing the field of medication safety, today announces it has signed a Letter of Intent with ASCP, a membership association...

TRHC : 63.46 (+7.30%)
Tabula Rasa Healthcare (TRHC) Q1 Earnings Match Estimates

Tabula Rasa Healthcare (TRHC) delivered earnings and revenue surprises of 0.00% and 1.86%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

TRHC : 63.46 (+7.30%)
Tabula Rasa Healthcare: 1Q Earnings Snapshot

MOORESTOWN, N.J. (AP) _ Tabula Rasa Healthcare Inc. (TRHC) on Thursday reported a loss of $14.4 million in its first quarter.

TRHC : 63.46 (+7.30%)
Tabula Rasa HealthCare Reports First Quarter 2020 Results

Tabula Rasa HealthCare(R), Inc. ("TRHC") (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, today reported financial results for the first quarter ended March 31,...

TRHC : 63.46 (+7.30%)
TRHC and Speed Script Expand Partnership for Clinical Documentation

Tabula Rasa HealthCare(R), Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced that Speed Script(R), a Kansas-based pharmacy management...

TRHC : 63.46 (+7.30%)
CPSI vs. TRHC: Which Stock Should Value Investors Buy Now?

CPSI vs. TRHC: Which Stock Is the Better Value Option?

CPSI : 22.37 (+1.13%)
TRHC : 63.46 (+7.30%)
Why Tabula Rasa Healthcare (TRHC) is Poised to Beat Earnings Estimates Again

Tabula Rasa Healthcare (TRHC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

TRHC : 63.46 (+7.30%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade TRHC with:

Business Summary

Tabula Rasa HealthCare, Inc. is a provider of patient-specific, data-driven technology and solutions which enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. The company's cloud-based software applications...

See More

Key Turning Points

2nd Resistance Point 66.58
1st Resistance Point 65.02
Last Price 63.46
1st Support Level 60.54
2nd Support Level 57.62

See More

52-Week High 69.72
Last Price 63.46
Fibonacci 61.8% 55.71
Fibonacci 50% 51.38
Fibonacci 38.2% 47.05
52-Week Low 33.04

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar